Founded in 2007, The Oncology Institute (NASDAQ: TOI) is the nation's leading value-based oncology group. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.7 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced healthcare organizations. With 100+ employed clinicians and over 700 teammates in 70 clinic locations and growing, TOI is changing oncology for the better.

Served as TOI's CEO from 2019-2023. During that time we were fortunate to achieve several milestones, including:- Completed a successful go-public process in 2021, listing on Nasdaq with an Enterprise Value of $843mm and a Market Capitalization of just under $1bn.- Expanded into 8 new markets and 3 new service lines- Pioneered new value-based contracting models- Raised more than $500mm of equity and debt capital - Completed more than a dozen add-on acquisitions- Improved employee engagement scores by nearly 50%- Increased Revenue and Gross Profit by more than 2x

Partnered with three private equity firms (Havencrest Capital Management, M33 Growth, and ROCA Partners) to lead a majority recapitalization of TOI in 2018. Joined TOI's Board of Directors following the recapitalization.

OrthoNebraska is the Midwest's leading provider of orthopedic and musculoskeletal care, with locations spanning Nebraska, Iowa, and Missouri. OrthoNebraska provides both surgical and non-surgical intervention, supported by a range of sub-specialized practitioners. The Company makes world-class orthopedic care more accessible and more personalized through a network of clinics, emergency, and urgent care services. Specialties include Emergency Room, Imaging, Joint Replacement, Non-Surgical Treatment, Orthopedic Urgent Care, Pain Management, Physical & Occupational Therapy, Sports Medicine, Spine Care, Podiatry, Surgery, and Workers’ Compensation. OrthoNebraska is supported by InTandem Capital Partners.

Unio is a multi-specialty physician practice management company focused on urology, gastroenterology and radiation oncology. With more than 200 providers and 800 teammates, Unio is one of the largest and fastest growing practice management companies in California. Unio is supported by Triton Pacific Capital Partners.

Served as Unio's Interim CEO (November 2023 - June 2024)

Teach classes on Healthcare Reform, Healthcare Finance, and Medical Group Management

Strategic Advisor: 2019 - PresentPrincipal / Investment Professional: 2016 - 2019Operating Partner: 2013 - 2016RLH Equity is a private equity firm that invests in high growth enterprises. Focused on business services, healthcare, and government services, RLH has a demonstrated track record of success over 30+ years. RLH provides capital and assists portfolio company management teams as they navigate the opportunities and challenges of rapid growth. The firm currently manages over $1 billion of assets and is actively seeking new portfolio companies.

Founded in 1996, Health Essentials is the largest post-acute physician group in California with ~300 physicians caring for patients in 400+ nursing homes. Through its Medical Group (GeriNet), its IPA (Health Essentials Physician Network), and its 8 Hospices, Health Essentials provides compassionate, value-based care to post-acute, long-term, and palliative care patients. Health Essentials is backed by world-class venture capital firms including Bessemer Ventures and SV Health Investors.

Heritage Provider Network is one of the largest and most progressive physician groups in the country. Through its network of over 30,000 physicians and hospitals, Heritage manages care for over 1 million patients. As a Knox-Keene licensed organization, Heritage takes accountability for the medical costs and the health outcomes of its patient population.